{{Rsnum
|rsid=2944755
|Gene=EIF2C2
|Chromosome=8
|position=140564095
|Orientation=minus
|GMAF=0.1488
|Gene_s=EIF2C2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 49.5 | 41.4 | 9.0
| HCB | 97.8 | 2.2 | 0.0
| JPT | 97.3 | 2.7 | 0.0
| YRI | 95.9 | 4.1 | 0.0
| ASW | 87.7 | 12.3 | 0.0
| CHB | 97.8 | 2.2 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 86.1 | 13.9 | 0.0
| LWK | 90.8 | 9.2 | 0.0
| MEX | 70.2 | 24.6 | 5.3
| MKK | 83.3 | 16.7 | 0.0
| TSI | 41.2 | 47.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=A
  |Pval=8E-6
  |OR=9.45
  |ORtxt=[5.31-13.59] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}